Herter & Co. advised private equity group Trilantic Europe on the financing of its acquisition of Oberberg Group (“Oberberg”), a leading operator of psychotherapy, psychiatry and psychosomatic acute clinics in Germany with a focus on treatments of depression and addictions.
Herter & Co. coordinated a financing package of more than €100m underwritten by a bank consortium. Closing and syndication of the financing are expected to take place before year end.
“We thank Herter & Co. for supporting us in executing this transaction in an accelerated manner. The Herter & Co. team was instrumental in putting together a financing package suitable for the company’s growth strategy” said Henrik Bodenstab, Partner at Trilantic Europe.
Oberberg Group operates nine clinics at eight locations with approximately 560 beds focused on privately insured patients. The clinics operate under different brands including Oberberg Kliniken, SOMNIA Privatkliniken, Rhein-Jura Klinik and Parkklinik Wiesbaden Schlangenbad. Oberberg differentiates itself through a unique therapy concept based on individual, intensive and innovative treatment delivery. This is accomplished by an experienced group of doctors who are leading experts in their respective fields and a strong patient-to-therapist ratio across the network of clinics.
Herter & Co. acted as Sole Debt Adviser to Trilantic Europe.
Trilantic Europe is a private equity firm focused on control and co-control investments in leading mid-market companies in Western Europe. Trilantic Europe currently manages two institutional private equity funds with aggregate capital commitments of €1.5 billion. In addition to the healthcare sector, Trilantic Europe invests across industries such as consumer & leisure, industrials, TMT and business services.